Article citationsMore>>

Bruera, G., Pepe, F., Malapelle, U., et al. (2018) KRAS, NRAS and BRAF Mutations Detected by Next Generation Sequencing, and Differential Clinical Outcome in Metastatic Colorectal Cancer (MCRC) Patients Treated with First Line FIr-B/FOx Adding Bevacizumab (BEV) to Triplet Chemotherapy. Oncotarget, 9, 26279-26290. https://doi.org/10.18632/oncotarget.25180

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top